BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 1755459)

  • 1. A prototype for ovulation detection: pros and cons.
    Lasley BL; Shideler SE; Munro CJ
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB; Holmes J; Barker G
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay.
    Munro CJ; Stabenfeldt GH; Cragun JR; Addiego LA; Overstreet JW; Lasley BL
    Clin Chem; 1991 Jun; 37(6):838-44. PubMed ID: 2049848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of the dual-analyte enzyme immunoassay for ovulation timing.
    Lenton EA; King H; Johnson J; Amos S
    Hum Reprod; 1989 May; 4(4):378-80. PubMed ID: 2663906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
    Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
    Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
    J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
    Blackwell LF; Brown JB; Vigil P; Gross B; Sufi S; d'Arcangues C
    Steroids; 2003 May; 68(5):465-76. PubMed ID: 12798498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring ovarian cycle activity via progestagens in urine and feces of female mountain gorillas: A comparison of EIA and LC-MS measurements.
    Habumuremyi S; Robbins MM; Fawcett KA; Deschner T
    Am J Primatol; 2014 Feb; 76(2):180-91. PubMed ID: 24123105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
    Dahl KD; Czekala NM; Lim P; Hsueh AJ
    J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using an ovarian monitor as an adjunct to natural family planning.
    Cavero C
    J Nurse Midwifery; 1995; 40(3):269-76. PubMed ID: 7798132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods of monitoring menstrual function in field studies: efficacy of methods.
    Kesner JS; Wright DM; Schrader SM; Chin NW; Krieg EF
    Reprod Toxicol; 1992; 6(5):385-400. PubMed ID: 1463919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of ovulation by urinary estrogen assays.
    Adlercreutz H; Lehtinen T; Kairento AL
    J Steroid Biochem; 1980 Jan; 12():395-401. PubMed ID: 7421224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of reference methods to monitor ovulation.
    Collins WP
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1994-6. PubMed ID: 1755456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
    Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
    Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.